Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Streamex Corp. Director's Dealing 2023

Aug 19, 2023

35540_dirs_2023-08-18_360a4c12-97ed-439d-9608-999db82c3a87.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BioSig Technologies, Inc. (BSGM)
CIK: 0001530766
Period of Report: 2023-08-15

Reporting Person: Klein James L (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-08-15 Common Stock A 16000 Acquired 299249 Direct

Footnotes

F1: The shares of restricted stock were granted in lieu of remuneration for the Company's 2023 second quarter board fees and shall be fully vested as of August 15, 2023, the date of the grant, based on a closing price of $0.6364 per share on such date.